Valuation: Sugentech Inc.

Market Cap 69.49B 51.77M 46.21M 43.02M 39.19M 73.66M 5.01B 74.43M 517M 202M 2.55B 194M 190M 8.2B P/E 2024
-5.35x
P/E 2025 -4.03x
Enterprise Value 39.29B 29.27M 26.13M 24.32M 22.16M 41.65M 2.83B 42.08M 292M 114M 1.44B 110M 107M 4.63B EV / Sales 2024
3.27x
EV / Sales 2025 6.76x
Free-Float
76.84%
Yield 2024 *
-
Yield 2025 -
1 day-7.06%
1 week+2.36%
Current month+2.36%
1 month+4.00%
3 months+20.72%
6 months+1.22%
Current year-25.98%
1 week 4,515
Extreme 4515
5,290
1 month 4,350
Extreme 4350
5,290
Current year 3,530
Extreme 3530
8,170
1 year 3,530
Extreme 3530
8,250
3 years 3,530
Extreme 3530
11,500
5 years 3,530
Extreme 3530
23,750
10 years 3,530
Extreme 3530
65,800
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 26/09/2017
Chief Executive Officer 61 26/09/2017
Director of Finance/CFO 56 31/03/2022
Director TitleAgeSince
Director/Board Member 61 26/09/2017
Director/Board Member 59 26/09/2017
Director/Board Member 51 31/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
02/04/24 Others 18,730 0.1120%
Change 5-day change 1-year change 3-year change Capi.($)
-7.06%+2.36%-35.81%-35.26% 55.81M
-0.24%-0.34%-25.96%+1.66% 171B
+2.62%+1.69%-10.76%+15.28% 109B
+0.57%+0.57%-24.99%+4.18% 106B
-2.49%-1.79%-48.26%-12.84% 75.43B
+1.29%+7.03%+4.09%+74.79% 60.54B
-0.44%+6.13%+10.95%+67.50% 53.16B
+1.44%+2.09%-5.08%-30.36% 49.07B
+1.28%-1.73%-18.20%+15.06% 39.92B
+0.13%-2.18%+27.84%+1.43% 31.81B
Average -0.29%+0.68%-12.62%+10.15% 69.58B
Weighted average by Cap. +0.43%+0.68%-16.03%+12.50%

Financials

2024 2025
Net sales 10.1B 7.52M 6.71M 6.25M 5.69M 10.7M 728M 10.81M 75.08M 29.37M 371M 28.23M 27.63M 1.19B 9.42B 7.02M 6.26M 5.83M 5.31M 9.98M 679M 10.09M 70.02M 27.39M 346M 26.33M 25.76M 1.11B
Net income -15.19B -11.32M -10.1M -9.4M -8.57M -16.1M -1.1B -16.27M -113M -44.2M -558M -42.48M -41.57M -1.79B -23.31B -17.37M -15.5M -14.43M -13.15M -24.71M -1.68B -24.97M -173M -67.82M -857M -65.19M -63.79M -2.75B
Net Debt -48.51B -36.14M -32.26M -30.03M -27.36M -51.42M -3.5B -51.95M -361M -141M -1.78B -136M -133M -5.72B -30.2B -22.5M -20.08M -18.7M -17.03M -32.01M -2.18B -32.35M -225M -87.86M -1.11B -84.45M -82.63M -3.56B
Projected Income Statement - Annual - Sugentech Inc.
Logo Sugentech Inc.
Sugentech Incorporate is a Korea-based company mainly engaged in the production and sale of in-vitro diagnostic test reagents. The Company is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The Company distributes its products within the domestic market and to overseas markets, including Indonesia.
Employees
148
Date Price Change Volume
08/10/26 ₩4,545.00 -7.06% 427,187
07/10/26 ₩4,890.00 +6.89% 3,859,938
06/10/26 ₩4,575.00 -0.54% 163,389
02/10/26 ₩4,600.00 +0.66% 101,270
01/10/26 ₩4,570.00 +2.93% 115,018
  1. Stock Market
  2. Stocks
  3. A253840 Stock